On Oct 26, 2021 Kadimastem closed a Post-IPO Equity round and raised $5,000,000 from Alpha Capital Anstalt, Clover Wolf Capital, Julien Ruggieri, Michel Revel, featuring […]
Series B – Cedilla Therapeutics
On Oct 25, 2021 Cedilla Therapeutics closed a Series B round and raised $25,000,000 from Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock […]
Series B – Cedilla Therapeutics
On Oct 25, 2021 Cedilla Therapeutics closed a Series B round and raised $25,000,000 from Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock […]
Grant – SeLux Diagnostics
On Oct 19, 2021 SeLux Diagnostics closed a Grant round and raised $2,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Debt Financing – Locus Biosciences
On Oct 19, 2021 Locus Biosciences closed a Debt Financing round and raised $25,000,000 from Hercules Capital, featuring lead investors Hercules Capital. About the company: […]
Series B – Scout Bio
On Oct 19, 2021 Scout Bio closed a Series B round and raised $33,000,000 from Adage Capital Management, Correlation Ventures, Digitalis Ventures, Frazier Healthcare Partners, […]
Series B – Scout Bio
On Oct 19, 2021 Scout Bio closed a Series B round and raised $33,000,000 from Adage Capital Management, Correlation Ventures, Digitalis Ventures, Frazier Healthcare Partners, […]
Seed Round – Anticancer Biosciences
On Oct 14, 2021 Anticancer Biosciences closed a Seed round and raised CN¥68,400,000 from 3 Rivers Capital, featuring lead investors 3 Rivers Capital. About the […]
Series A – Rectify Pharmaceuticals
On Oct 14, 2021 Rectify Pharmaceuticals closed a Series A round and raised $100,000,000 from Atlas Venture, Forbion Capital Partners, Longwood Fund, Omega Funds, featuring […]
Series B – IOmx Therapeutics
On Oct 5, 2021 IOmx Therapeutics closed a Series B round and raised €65,000,000 from ATHOS Service, M Ventures, MIG, Sofinnova Partners, Wellington Partners, featuring […]
